leon-nanodrugs appoints Dr. Wolfgang Hofmann as Chief Executive Officer
We are pleased to announce the appointment of Dr. Wolfgang Hofmann as its new Chief Executive Officer (CEO). With his extensive experience in…
Excited to Join the 2025 BIO International Convention in Boston – See You June 16–19!
We’re excited to attend the 2025 BIO International Convention in Boston from June 16–19. CONTACT US to set up a meeting
Enhancing Small Molecule Solubility: Advancing Liposomal Drug Delivery with FR-JET®
We’re excited to share a case study on our successful collaboration with Glatt, highlighting how our FR-JET® technology enables superior liposomal…
Feasibility Study with Evonik Confirms LEON’s FR-JET Technology’s Performance in Advanced Nanoparticle Manufacturing for Drug Delivery
We are pleased to announce the successful conclusion of an independent feasibility study with Evonik Canada Inc., part of Evonik Industries, one of…
leon-nanodrugs secures funds in a series D financing
LEON announced today the closing of a Series D financing round. New lead investor LBBW Venture Capital closed the round together with new investors…
Technical Evaluation by CMAC
In a significant stride towards advancing nanoparticle drug delivery manufacturing technology, LEON proudly announces a pioneering technical…
NANOme® has been honored with the prestigious iF Design Award 2024
Our NANOme® device has been honored with the prestigious iF Design Award! This award is a great recognition, not only of LEON´s innovative design,…
LEON appoints Dr. Setu Kasera as Chief Scientific Officer
leon-nanodrugs GmbH (“LEON”), announced today the appointment of Dr. Setu Kasera as Chief Scientific Officer, effective May 15, 2023. Since October…
LEON sets up lab facilities at the Innovation and Start-Up Center for Biotechnology (IZB) in Munich
leon-nanodrugs GmbH, announced today the establishment of their own lab facilities at the Start-Up Center for Biotechnology (IZB) in Munich. The new…
LEON successfully completes development of its innovative reactor for more efficient production of lipid nanoparticles
LEON achieved superior accuracy in development of its proprietary reactor, facilitating exceptional inter-device reproducibility of particle size and…